Update on feline alphaherpesvirus‐1 seroprevalence in Victorian feral and owned cats
The seroprevalence of feline alphaherpesvirus‐1 (FHV‐1) in feral cats in Victoria, Australia, was last assessed in 1981 when serum‐virus‐neutralising antibodies (VNAb) against FHV‐1 were detected in 11% of the sampled population from two Victorian locations. In this current study, VNAb were assessed...
Gespeichert in:
| Veröffentlicht in: | Australian veterinary journal 2022-05, Vol.100 (5), p.187-189 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 189 |
|---|---|
| container_issue | 5 |
| container_start_page | 187 |
| container_title | Australian veterinary journal |
| container_volume | 100 |
| creator | Cottingham, E Johnstone, T Hartley, CA Devlin, JM |
| description | The seroprevalence of feline alphaherpesvirus‐1 (FHV‐1) in feral cats in Victoria, Australia, was last assessed in 1981 when serum‐virus‐neutralising antibodies (VNAb) against FHV‐1 were detected in 11% of the sampled population from two Victorian locations. In this current study, VNAb were assessed in serum from feral cats located in Phillip Island, Point Cook and Hattah in the Mallee region in Northern Victoria. In feral cats, the seroprevalence of VNAb to FHV‐1 was highest in Point Cook at 24.6% (17/69), followed by Phillip Island at 16.7% (11/66) and Hattah where no feral cats had detectable VNAb to FHV‐1 (0/12). In contrast, virus‐neutralising antibodies were observed in 84.1% (37/44) of Victorian‐owned cats. This higher seroprevalence in owned cats is likely due to the use of FHV‐1 vaccines; however, the vaccination history of the cats was not known and the development of neutralising antibodies after infection or vaccination can vary. The results are useful for understanding FHV‐1 exposure in feral and owned cats and are important background information in the context of any potential future use of FHV‐1‐vectored vaccines. |
| doi_str_mv | 10.1111/avj.13147 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9306845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2658055645</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4037-619105454606de63eb146a74e6d959f06766ed306890b07f798b483674753b7b3</originalsourceid><addsrcrecordid>eNp1kc1u1DAURi0EokNhwQsgS2xgkfY6_ks2SFVVaKtKbOhsLSe5YTzK2MFOpuqOR-gz8iR4Om0FSNyNF_f46Lv6CHnL4IjlObbb9RHjTOhnZMG0ZAVUjD8nCwCQBYiSH5BXKa0BuJalfEkOuIQKgLEFWV6PnZ2QBk97HJxHaodxZVcYR0xbF-f06-cdowljGCNu7YC-Reo8Xbp2CtHZ3b9oB2p9R8ONx462dkqvyYveDgnfPLyH5Prz2bfT8-Lq65eL05OrohU5TKFYzUAKKRSoDhXHhglltUDV1bLuQWmlsOOgqhoa0L2uq0ZUXGmhJW90ww_Jp713nJsNdi36KYcxY3QbG29NsM78vfFuZb6Hral3UiGz4MODIIYfM6bJbFxqcRisxzAnU6qyrBXnQmf0_T_oOszR5_MyJSuQUt0LP-6pNoaUIvZPYRiYXVsmt2Xu28rsuz_TP5GP9WTgeA_cuAFv_28yJ8vLvfI3MvmedQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2658055645</pqid></control><display><type>article</type><title>Update on feline alphaherpesvirus‐1 seroprevalence in Victorian feral and owned cats</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Cottingham, E ; Johnstone, T ; Hartley, CA ; Devlin, JM</creator><creatorcontrib>Cottingham, E ; Johnstone, T ; Hartley, CA ; Devlin, JM</creatorcontrib><description>The seroprevalence of feline alphaherpesvirus‐1 (FHV‐1) in feral cats in Victoria, Australia, was last assessed in 1981 when serum‐virus‐neutralising antibodies (VNAb) against FHV‐1 were detected in 11% of the sampled population from two Victorian locations. In this current study, VNAb were assessed in serum from feral cats located in Phillip Island, Point Cook and Hattah in the Mallee region in Northern Victoria. In feral cats, the seroprevalence of VNAb to FHV‐1 was highest in Point Cook at 24.6% (17/69), followed by Phillip Island at 16.7% (11/66) and Hattah where no feral cats had detectable VNAb to FHV‐1 (0/12). In contrast, virus‐neutralising antibodies were observed in 84.1% (37/44) of Victorian‐owned cats. This higher seroprevalence in owned cats is likely due to the use of FHV‐1 vaccines; however, the vaccination history of the cats was not known and the development of neutralising antibodies after infection or vaccination can vary. The results are useful for understanding FHV‐1 exposure in feral and owned cats and are important background information in the context of any potential future use of FHV‐1‐vectored vaccines.</description><identifier>ISSN: 0005-0423</identifier><identifier>EISSN: 1751-0813</identifier><identifier>DOI: 10.1111/avj.13147</identifier><identifier>PMID: 35080011</identifier><language>eng</language><publisher>Melbourne: Wiley Publishing Asia Pty Ltd</publisher><subject>Animals ; Animals, Wild ; Antibodies ; Antibodies, Neutralizing ; Antibodies, Viral ; Cat Diseases - epidemiology ; Cats ; feline herpesvirus ; feral cats ; Feral populations ; Herpesviridae Infections - epidemiology ; Herpesviridae Infections - veterinary ; Immunization ; Mallee ; Seroepidemiologic Studies ; Serology ; seroprevalence ; Short Communication ; Small Animals ; Vaccines ; Varicellovirus ; Victoria - epidemiology</subject><ispartof>Australian veterinary journal, 2022-05, Vol.100 (5), p.187-189</ispartof><rights>2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian Veterinary Association.</rights><rights>2022 The Authors. Australian Veterinary Journal published by John Wiley & Sons Australia, Ltd on behalf of Australian Veterinary Association.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4037-619105454606de63eb146a74e6d959f06766ed306890b07f798b483674753b7b3</cites><orcidid>0000-0002-2399-8657</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Favj.13147$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Favj.13147$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35080011$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cottingham, E</creatorcontrib><creatorcontrib>Johnstone, T</creatorcontrib><creatorcontrib>Hartley, CA</creatorcontrib><creatorcontrib>Devlin, JM</creatorcontrib><title>Update on feline alphaherpesvirus‐1 seroprevalence in Victorian feral and owned cats</title><title>Australian veterinary journal</title><addtitle>Aust Vet J</addtitle><description>The seroprevalence of feline alphaherpesvirus‐1 (FHV‐1) in feral cats in Victoria, Australia, was last assessed in 1981 when serum‐virus‐neutralising antibodies (VNAb) against FHV‐1 were detected in 11% of the sampled population from two Victorian locations. In this current study, VNAb were assessed in serum from feral cats located in Phillip Island, Point Cook and Hattah in the Mallee region in Northern Victoria. In feral cats, the seroprevalence of VNAb to FHV‐1 was highest in Point Cook at 24.6% (17/69), followed by Phillip Island at 16.7% (11/66) and Hattah where no feral cats had detectable VNAb to FHV‐1 (0/12). In contrast, virus‐neutralising antibodies were observed in 84.1% (37/44) of Victorian‐owned cats. This higher seroprevalence in owned cats is likely due to the use of FHV‐1 vaccines; however, the vaccination history of the cats was not known and the development of neutralising antibodies after infection or vaccination can vary. The results are useful for understanding FHV‐1 exposure in feral and owned cats and are important background information in the context of any potential future use of FHV‐1‐vectored vaccines.</description><subject>Animals</subject><subject>Animals, Wild</subject><subject>Antibodies</subject><subject>Antibodies, Neutralizing</subject><subject>Antibodies, Viral</subject><subject>Cat Diseases - epidemiology</subject><subject>Cats</subject><subject>feline herpesvirus</subject><subject>feral cats</subject><subject>Feral populations</subject><subject>Herpesviridae Infections - epidemiology</subject><subject>Herpesviridae Infections - veterinary</subject><subject>Immunization</subject><subject>Mallee</subject><subject>Seroepidemiologic Studies</subject><subject>Serology</subject><subject>seroprevalence</subject><subject>Short Communication</subject><subject>Small Animals</subject><subject>Vaccines</subject><subject>Varicellovirus</subject><subject>Victoria - epidemiology</subject><issn>0005-0423</issn><issn>1751-0813</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAURi0EokNhwQsgS2xgkfY6_ks2SFVVaKtKbOhsLSe5YTzK2MFOpuqOR-gz8iR4Om0FSNyNF_f46Lv6CHnL4IjlObbb9RHjTOhnZMG0ZAVUjD8nCwCQBYiSH5BXKa0BuJalfEkOuIQKgLEFWV6PnZ2QBk97HJxHaodxZVcYR0xbF-f06-cdowljGCNu7YC-Reo8Xbp2CtHZ3b9oB2p9R8ONx462dkqvyYveDgnfPLyH5Prz2bfT8-Lq65eL05OrohU5TKFYzUAKKRSoDhXHhglltUDV1bLuQWmlsOOgqhoa0L2uq0ZUXGmhJW90ww_Jp713nJsNdi36KYcxY3QbG29NsM78vfFuZb6Hral3UiGz4MODIIYfM6bJbFxqcRisxzAnU6qyrBXnQmf0_T_oOszR5_MyJSuQUt0LP-6pNoaUIvZPYRiYXVsmt2Xu28rsuz_TP5GP9WTgeA_cuAFv_28yJ8vLvfI3MvmedQ</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Cottingham, E</creator><creator>Johnstone, T</creator><creator>Hartley, CA</creator><creator>Devlin, JM</creator><general>Wiley Publishing Asia Pty Ltd</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2399-8657</orcidid></search><sort><creationdate>202205</creationdate><title>Update on feline alphaherpesvirus‐1 seroprevalence in Victorian feral and owned cats</title><author>Cottingham, E ; Johnstone, T ; Hartley, CA ; Devlin, JM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4037-619105454606de63eb146a74e6d959f06766ed306890b07f798b483674753b7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Animals, Wild</topic><topic>Antibodies</topic><topic>Antibodies, Neutralizing</topic><topic>Antibodies, Viral</topic><topic>Cat Diseases - epidemiology</topic><topic>Cats</topic><topic>feline herpesvirus</topic><topic>feral cats</topic><topic>Feral populations</topic><topic>Herpesviridae Infections - epidemiology</topic><topic>Herpesviridae Infections - veterinary</topic><topic>Immunization</topic><topic>Mallee</topic><topic>Seroepidemiologic Studies</topic><topic>Serology</topic><topic>seroprevalence</topic><topic>Short Communication</topic><topic>Small Animals</topic><topic>Vaccines</topic><topic>Varicellovirus</topic><topic>Victoria - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cottingham, E</creatorcontrib><creatorcontrib>Johnstone, T</creatorcontrib><creatorcontrib>Hartley, CA</creatorcontrib><creatorcontrib>Devlin, JM</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Australian veterinary journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cottingham, E</au><au>Johnstone, T</au><au>Hartley, CA</au><au>Devlin, JM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Update on feline alphaherpesvirus‐1 seroprevalence in Victorian feral and owned cats</atitle><jtitle>Australian veterinary journal</jtitle><addtitle>Aust Vet J</addtitle><date>2022-05</date><risdate>2022</risdate><volume>100</volume><issue>5</issue><spage>187</spage><epage>189</epage><pages>187-189</pages><issn>0005-0423</issn><eissn>1751-0813</eissn><abstract>The seroprevalence of feline alphaherpesvirus‐1 (FHV‐1) in feral cats in Victoria, Australia, was last assessed in 1981 when serum‐virus‐neutralising antibodies (VNAb) against FHV‐1 were detected in 11% of the sampled population from two Victorian locations. In this current study, VNAb were assessed in serum from feral cats located in Phillip Island, Point Cook and Hattah in the Mallee region in Northern Victoria. In feral cats, the seroprevalence of VNAb to FHV‐1 was highest in Point Cook at 24.6% (17/69), followed by Phillip Island at 16.7% (11/66) and Hattah where no feral cats had detectable VNAb to FHV‐1 (0/12). In contrast, virus‐neutralising antibodies were observed in 84.1% (37/44) of Victorian‐owned cats. This higher seroprevalence in owned cats is likely due to the use of FHV‐1 vaccines; however, the vaccination history of the cats was not known and the development of neutralising antibodies after infection or vaccination can vary. The results are useful for understanding FHV‐1 exposure in feral and owned cats and are important background information in the context of any potential future use of FHV‐1‐vectored vaccines.</abstract><cop>Melbourne</cop><pub>Wiley Publishing Asia Pty Ltd</pub><pmid>35080011</pmid><doi>10.1111/avj.13147</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2399-8657</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0005-0423 |
| ispartof | Australian veterinary journal, 2022-05, Vol.100 (5), p.187-189 |
| issn | 0005-0423 1751-0813 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9306845 |
| source | MEDLINE; Wiley Journals |
| subjects | Animals Animals, Wild Antibodies Antibodies, Neutralizing Antibodies, Viral Cat Diseases - epidemiology Cats feline herpesvirus feral cats Feral populations Herpesviridae Infections - epidemiology Herpesviridae Infections - veterinary Immunization Mallee Seroepidemiologic Studies Serology seroprevalence Short Communication Small Animals Vaccines Varicellovirus Victoria - epidemiology |
| title | Update on feline alphaherpesvirus‐1 seroprevalence in Victorian feral and owned cats |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A00%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Update%20on%20feline%20alphaherpesvirus%E2%80%901%20seroprevalence%20in%20Victorian%20feral%20and%20owned%20cats&rft.jtitle=Australian%20veterinary%20journal&rft.au=Cottingham,%20E&rft.date=2022-05&rft.volume=100&rft.issue=5&rft.spage=187&rft.epage=189&rft.pages=187-189&rft.issn=0005-0423&rft.eissn=1751-0813&rft_id=info:doi/10.1111/avj.13147&rft_dat=%3Cproquest_pubme%3E2658055645%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2658055645&rft_id=info:pmid/35080011&rfr_iscdi=true |